1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CORCEPT THERAPEUTICS INC
Corcept Therapeutics Inc XNAS: CORT
34.17 0.63 (1.88%)
582.8K
XNAS Volume

XNAS 11 Mar, 2026 3:23 PM (EDT)

Watchlist

Portfolio

Alert

Corcept Therapeutics Inc - CORT - stock price prediction, stock price target, analyst ratings from 6 analysts

Corcept Therapeutics Inc has a share price target of US$ 65, revenue growth forecast of 22.8%, and profit growth estimate of -59.0% for FY26, based on top 6 analyst calls.